| |
Article Title |
Author(s) |
Type |
Pages |
|
Biopharmaceuticals and biosimilars in psoriasis: What the dermatologist needs to know
February 2012 (Vol. 66 | No. 2 | Pages 317-322)
|
Bruce E. Strober,
Katherine Armour,
Ricardo Romiti,
Catherine Smith,
Paul W. Tebbey,
Alan Menter,
Craig Leonardi
et al.
|
Editorial
|
317-322
|
|
Current status of the sunscreen regulation in the United States: 2011 Food and Drug Administration’s final rule on labeling and effectiveness testing
October 2011 (Vol. 65 | No. 4 | Pages 863-869)
|
Steven Q. Wang,
Henry W. Lim
|
Editorial
|
863-869
|
|
Why are there significant differences in published narrowband ultraviolet B dosimetry recommendations? The need for national standardization of phototherapy treatment
August 2011 (Vol. 65 | No. 2 | Pages 411-414)
|
Madelaine M. Haddican,
Tina Bhutani,
Patricia B. McClelland,
John Y.M. Koo
|
Editorial
|
411-414
|
|
POEMS syndrome: Are current diagnostic criteria too exclusive?
August 2011 (Vol. 65 | No. 2 | Pages 415-417)
|
Yann Charli-Joseph,
Mónica Fernández-Sánchez,
Marcela Saeb-Lima,
Rocío Orozco-Topete
|
Editorial
|
415-417
|
|
Isotretinoin and iPledge: A view of results
August 2011 (Vol. 65 | No. 2 | Pages 418-419)
|
Mary E. Maloney,
Stephen P. Stone
|
Editorial
|
418-419
|
|
Consequences of systemic absorption of topical glucocorticoids
July 2011 (Vol. 65 | No. 1 | Pages 250-252)
|
Lynnette K. Nieman
|
Editorial
|
250-252
|
|
Physician performance measurement: Tiered networks and dermatology (An opportunity and a challenge)
June 2011 (Vol. 64 | No. 6 | Pages 1164-1169)
|
John D. Freedman,
Alice Bendix Gottlieb,
Paul F. Lizzul
|
Editorial
|
1164-1169
|
|
Pemphigus: Directions for the future
May 2011 (Vol. 64 | No. 5 | Pages 909-910)
|
Linda K. Martin,
Dédée F. Murrell
|
Editorial
|
909-910
|
|
Scientific developments in indoor tanning and melanoma
April 2011 (Vol. 64 | No. 4 | Pages 783-785)
|
Linda Ratanaprasatporn,
Jason Neustadter,
Martin A. Weinstock
|
Editorial
|
783-785
|
|
Why a new section dedicated to ethics in the JAAD?
February 2011 (Vol. 64 | No. 2 | Pages 432-433)
|
Jane M. Grant-Kels,
Lionel Bercovitch
|
Editorial
|
432-433
|
|
Understanding over-the-counter medications and prescription devices for eczema: Potential consequences for consumers
December 2010 (Vol. 63 | No. 6 | Pages 1094-1098)
|
Julie S. Green,
Kristen Andersen,
Jonathan Wilkin,
Elaine Siegfried
|
Editorial
|
1094-1098
|
|
Safety of retinyl palmitate in sunscreens: A critical analysis
November 2010 (Vol. 63 | No. 5 | Pages 903-906)
|
Steven Q. Wang,
Stephen W. Dusza,
Henry W. Lim
|
Editorial
|
903-906
|
|
An analysis of health system reform for dermatologists: Elements and implications of the Patient Protection and Affordable Care Act
October 2010 (Vol. 63 | No. 4 | Pages 706-715)
|
Jack S. Resneck
|
Editorial
|
706-715
|
|
Refractory ulcers: The role of tumor necrosis factor–α
July 2010 (Vol. 63 | No. 1 | Pages 146-154)
|
David A. Weinstein,
Robert S. Kirsner
|
Editorial
|
146-154
|
|
Look out, dermatology: Here comes Wal-Mart
July 2004 (Vol. 51 | No. 1 | Pages E1-E2)
|
Robert A Swerlick
|
Discussion
|
E1-E2
|
|
Reply
July 2004 (Vol. 51 | No. 1 | Pages E3-E4)
|
Peyton E Weary
|
Discussion
|
E3-E4
|
|
Coping with SARS: a day in the life of a United Kingdom dermatologist in Singapore General Hospital
March 2004 (Vol. 50 | No. 3 | Pages e3-e5)
|
Malcolm W Greaves
|
Editorial
|
e3-e5
|
